-
MITSUBISHI TANABE PHARMA CORPORATION et al v. SANDOZ INC. et al DC CAFC
- 3:17-cv-05319
- D.N.J.
- Judge: Freda L. Wolfson
+1
- Filed: 07/20/2017
- Closed: 04/05/2021
- Latest Docket Entry: 02/15/2022
- PACER
- Docket updated daily
5
Plaintiffs
2
Defendants
7
Accused
Products
3
Patents-in-Suit
1,356
Days in
Litigation
-
MITSUBISHI TANABE PHARMA CORPORATION et al v. SANDOZ INC. et al DC CAFC
- 3:17-cv-05319
- D.N.J.
- Judge: Freda L. Wolfson
+1
- Filed: 07/20/2017
- Closed: 04/05/2021
- Latest Docket Entry: 02/15/2022
- PACER
- Docket updated daily
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
-
Infringement
Zydus Pharmaceuticals (USA) Inc.
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| NA | US 7,943,788 B2 |
12, 20
|
Infringement
Entry 247
|
| canagliflozin and metformin hydrochloride tablets 150 mg/1 gcanagliflozin and metformin hydrochloride tablets 150 mg/500 mgcanagliflozin and metformin hydrochloride tablets 50 mg/1 gcanagliflozin and metformin hydrochloride tablets 50 mg/500 mgcanagliflozin tablets 100 mgcanagliflozin tablets 300 mg | US 8,222,219 B2 |
22
|
Infringement
Entry 247
|
| canagliflozin and metformin hydrochloride tablets 150 mg/1 gcanagliflozin and metformin hydrochloride tablets 150 mg/500 mgcanagliflozin and metformin hydrochloride tablets 50 mg/1 gcanagliflozin and metformin hydrochloride tablets 50 mg/500 mgcanagliflozin tablets 100 mgcanagliflozin tablets 300 mg | US 8,785,403 B2 |
26
|
Infringement
Entry 247
|
